[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368646-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368646-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","transcriptomic-profile-of-oral-cancer-lesions-a-proof-of-concept-pilot-study-of-ffpe-tissue-sections","Transcriptomic Profile of Oral Cancer Lesions - A Proof-of-Concept Pilot Study of FFPE Tissue Sections","","Oral squamous cell carcinoma (OSCC) arises from oral potentially malignant disorders (OPMDs) and presents indurated oral lesions. This proof-of-concept study uses RNAseq from formalin-fixed, paraffin-embedded (FFPE) tissues, leveraging long-term preservation to obtain transcriptomic signatures relevant to gene fusions, isoforms, and allele-specific expression. OSCC FFPE samples (N=3) collected 3–5 years after OPMD diagnosis were compared with publicly available FFPE breast cancer (BC) data (n=6) to identify OSCC-versus-BC differentially expressed genes and enriched pathways.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/transcriptomic-profile-of-oral-cancer-lesions-a-proof-of-concept-pilot-study-of-ffpe-tissue-sections/368646/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/transcriptomic-profile-of-oral-cancer-lesions-a-proof-of-concept-pilot-study-of-ffpe-tissue-sections/368646.png","ImageObject",300,407,{"name":42,"@type":43},"Nguyễn Văn Học","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study designed to evaluate?","Question",{"text":63,"@type":64},"The study evaluates transcriptomic profiles of oral cancer lesions using RNAseq data generated from FFPE tissue sections, focusing on OSCC and comparing them to publicly available BC FFPE data.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were OSCC samples selected in relation to OPMD?",{"text":68,"@type":64},"OSCC FFPE samples came from patients (N=3) who developed OSCC 3 to 5 years after being diagnosed with OPMD (n=3).",{"name":70,"@type":61,"acceptedAnswer":71},"Which analysis steps and tools were used to identify differential expression and pathways?",{"text":72,"@type":64},"RNAseq alignment was performed with STAR, differential expression with DESeq2, visualization with PCA, pathway analysis with Pathview, and protein–protein interaction assessment with STRING.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368646,1790196274,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","Communication  \nTranscriptomic Profile of Oral Cancer Lesions: A  \nProof-of-Concept Pilot Study of FFPE Tissue Sections  \nMadison E. Richards 1, Micaela F. Beckman 2, Ernesto Martinez Duarte 3, Joel J. Napenas 1, Michael T. Brennan 1,4,*, Farah Bahrani Mougeot 1,2,4, * and Jean-Luc C. Mougeot 1,2,4  \nAcademic Editor: Lorenzo Azzi  \nReceived: 23 May 2025  \nRevised: 18 June 2025  \nAccepted: 26 June 2025  \nPublished: 28 June 2025  \nCitation: Richards, M.E.; Beckman, M.F.; Martinez Duarte, E.; Napenas, J.J.; Brennan, M.T.; Bahrani Mougeot, F.; Mougeot, J.-L.C. Transcriptomic Profile of Oral Cancer Lesions: A Proof-of-Concept Pilot Study ofFFPETissue Sections. Int. J. Mol. Sci. 2025, 26, 6263. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26136263  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Oral Medicine/Oral and Maxillofacial Surgery, Atrium Health Carolinas Medical Center, Charlotte, NC 28203, USA; [madison.richards@atriumhealth.org](madison.richards@atriumhealth.org) (M.E.R.);  \n[joel.napenas@atriumhealth.org](joel.napenas@atriumhealth.org) (J.J.N.); [jean-luc.mougeot@atriumhealth.org](jean-luc.mougeot@atriumhealth.org) (J.-L.C.M.)  \n2 Translational Research Laboratories, Cannon Research Center & Oral Medicine, Atrium Health Carolinas Medical Center, Charlotte, NC 28203, USA; [micaela.beckman@atriumhealth.org](micaela.beckman@atriumhealth.org)  \n3 Carolinas Pathology Group, Atrium Health Carolinas Medical Center, Charlotte, NC 28203, USA; [ernesto.martinezduarte@atriumhealth.org](ernesto.martinezduarte@atriumhealth.org)  \n4 Department of Otolaryngology/Head and Neck Surgery, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA  \n* [Correspondence: mike.brennan@atriumhealth.org](Correspondence: mike.brennan@atriumhealth.org) (M.T.B.); [farah.mougeot@atriumhealth.org](farah.mougeot@atriumhealth.org) (F.B.M.)  \nAbstract  \nOral squamous cell carcinoma (OSCC) is a malignancy that affects the oral mucosa and is characterized by indurated oral lesions. The RNAseq of formalin-fixed, paraffin-embedded (FFPE) samples is readily available in clinical settings. Such samples have long-term preservation and can provide highly accurate transcriptomic information regarding gene fusions, isoforms, and allele-specific expression. We determined differentially expressed genes using the transcriptomic profiles of oral potentially malignant disorder (OPMD) FFPE oral lesion samples of patients who developed OSCC over years. A technical comparison was completed comparing breast cancer (BC) FFPE publicly available data in this proofof-concept pilot study. OSCC FFPE samples were collected from patients (N = 3) who developed OSCC 3 to 5 years following OPMD diagnosis (n = 3) and were analyzed using RNAseq. RNAseq sequences from the FFPE OSCC samples and publicly available FFPE samples of BC patients (n = 6) (Gene Expression Omnibus Database, GSE58135) aligned to human reference (GRCh38.p13) . Genes were counted using the Spliced Transcripts Alignment to a Reference (STARv2.7.9a) software. Differential expression was determined in R using DESeq2v1.40.2 comparing OSCC to BC samples. Principal component analysis (PCA) plots were completed. Differential Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were determined via the Pathviewv.1.40.0 program. STRING v12.0 was used to determine protein–protein interactions between genes represented in more than one KEGG pathway. STARv2.7.9a identified 27,237 and 30,343 genes among the OSCC and BC groups, respectively. DESeq2v1.40.2 determined 9194 differentially expressed genes (DEPs), 4466 being upregulated (OSCC > BC) and 4728 being downregulated","cbCaii9IfS1DR94H","https://ap.wps.com/l/cbCaii9IfS1DR94H","pdf",3239655,16,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What is the study designed to evaluate?\",\"answer\":\"The study evaluates transcriptomic profiles of oral cancer lesions using RNAseq data generated from FFPE tissue sections, focusing on OSCC and comparing them to publicly available BC FFPE data.\"},{\"question\":\"How were OSCC samples selected in relation to OPMD?\",\"answer\":\"OSCC FFPE samples came from patients (N=3) who developed OSCC 3 to 5 years after being diagnosed with OPMD (n=3).\"},{\"question\":\"Which analysis steps and tools were used to identify differential expression and pathways?\",\"answer\":\"RNAseq alignment was performed with STAR, differential expression with DESeq2, visualization with PCA, pathway analysis with Pathview, and protein–protein interaction assessment with STRING.\"}]","Transcriptomic Profile of Oral Cancer Lesions - A Proof-of-Concept Pilot Study of FFPE Tissue Sections | PDF",1790177840,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab1d60a715ea69fe9de571466785c520.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84a227a07a65210bad4140b52893b7c9.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf42bd2a7db3143a13200ac019866027.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/130c823f61217b669abbb126ac313e42.webp",980,1385]